IMATEN 400

IMATEN 400 Tablet is indicated for the management of various cancer types, particularly effective in treating hematological malignancies such as chronic myeloid leukemia and acute lymphocytic leukemia, as well as gastrointestinal stromal tumors. The mechanism of action involves the inhibition of specific proteins that facilitate the proliferation and dissemination of cancer cells. Additionally, IMATEN is utilized in the treatment of dermatofibrosarcoma protuberans, a form of skin cancer, and aggressive systemic mastocytosis, a bone marrow disorder. For optimal results, it is recommended to take the tablet alongside food and at consistent intervals each day. Adherence to the prescribed regimen is essential, and the treatment duration will depend on individual response and medical advice. It is important to follow dosing instructions precisely, as incorrect usage or excessive intake may lead to severe adverse effects. Although therapeutic benefits may take weeks or even months to manifest, do not discontinue the medication without consulting your healthcare provider. Common adverse reactions may include swelling, nausea, vomiting, muscle cramps, pain in the bones and joints, diarrhea, skin rashes, fatigue, and abdominal discomfort. Patients should inform their doctor of any sudden weight increase and may require regular assessment of hematologic parameters and liver function during therapy. If dizziness or blurred vision occurs, avoid driving or activities requiring concentration. It is crucial to inform your healthcare team of all concurrent medications, as interactions may occur. Use of effective contraceptive measures is essential for both men and women during the treatment period, as the medication is contraindicated in pregnancy and breastfeeding.